Literature DB >> 3001360

Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes.

C A Rosen, J G Sodroski, K Campbell, W A Haseltine.   

Abstract

Recombinant retroviruses containing the trans activator genes of human T-cell leukemia virus (HTLV) type II and human T-cell lymphotropic virus type III were constructed. The trans activator genes tat II and tat III were inserted into the murine retroviral vector pZIPNEOSV(X)1. Recombinant plasmids were transfected into the psi 2 and psi AM packaging cell lines that produce murine leukemia virions containing no retroviral RNA. Functional tat II and tat III gene products were expressed as demonstrated by trans activation of HTLV type I and II and human T-cell lymphotropic virus type III long terminal repeat-directed gene expression in the respective infected cells. Use of these recombinant vectors permits high-efficiency gene transfer into a wide variety of cells, thereby providing the opportunity to study the biochemical effects associated with tat II and tat III gene expression.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3001360      PMCID: PMC252741     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  A pathogenic retrovirus (HTLV-III) linked to AIDS.

Authors:  S Broder; R C Gallo
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

2.  Construction and applications of a highly transmissible murine retrovirus shuttle vector.

Authors:  C L Cepko; B E Roberts; R C Mulligan
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

3.  Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor.

Authors:  J Fujisawa; M Seiki; T Kiyokawa; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

Authors:  J Sodroski; C Rosen; F Wong-Staal; S Z Salahuddin; M Popovic; S Arya; R C Gallo; W A Haseltine
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  A molecular clone of HTLV-III with biological activity.

Authors:  A G Fisher; E Collalti; L Ratner; R C Gallo; F Wong-Staal
Journal:  Nature       Date:  1985 Jul 18-24       Impact factor: 49.962

6.  Insertion mutagenesis of embryonal carcinoma cells by retroviruses.

Authors:  W King; M D Patel; L I Lobel; S P Goff; M C Nguyen-Huu
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

7.  High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range.

Authors:  R D Cone; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

8.  A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus.

Authors:  J Sodroski; C Rosen; W C Goh; W Haseltine
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

9.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

Authors:  S K Arya; C Guo; S F Josephs; F Wong-Staal
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

10.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  41 in total

1.  Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.

Authors:  S L Zeichner; J Y Kim; J C Alwine
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine.

Authors:  B D Walker; M Kowalski; W C Goh; K Kozarsky; M Krieger; C Rosen; L Rohrschneider; W A Haseltine; J Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Independent fluctuation of human immunodeficiency virus type 1 rev and gp41 quasispecies in vivo.

Authors:  L P Martins; N Chenciner; B Asjö; A Meyerhans; S Wain-Hobson
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication.

Authors:  P A Luciw; C Cheng-Mayer; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence.

Authors:  S Roy; N T Parkin; C Rosen; J Itovitch; N Sonenberg
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  The secondary structure of the R region of a murine leukemia virus is important for stimulation of long terminal repeat-driven gene expression.

Authors:  L Cupelli; S A Okenquist; A Trubetskoy; J Lenz
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Isolation and characterization of a dideoxyguanosine triphosphate-resistant mutant of human immunodeficiency virus reverse transcriptase.

Authors:  V R Prasad; I Lowy; T de los Santos; L Chiang; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

8.  Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences.

Authors:  S Y Choi; K van de Mark; D V Faller
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation.

Authors:  R J Shattock; J S Friedland; G E Griffin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in T lymphocytes requires CD4-gp120 binding.

Authors:  A Marcuzzi; I Lowy; O K Weinberger
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.